15616383 15922257 16507192 23276931 24502570 17704286 24610035 15108967 27040058 20435992 18922439 24351506 16508397 16815986 17717216 22683156 26190257 21565202 28395591 16325209 21109464 25186820 26045455 16508399 19020121 21659557 17555610 2304422 - Search Results

Year	Number of Results
2004	6
2005	9
2006	9
2007	6
2008	11
2009	11
2010	11
2011	8
2012	9
2013	4
2014	9
2015	5
2016	3
2017	1
2020	1
2023	0

1

ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction.

Pollesello P, Mebazaa A. Pollesello P, et al. Curr Opin Crit Care. 2004 Dec;10(6):436-41. doi: 10.1097/01.ccx.0000145099.20822.19. Curr Opin Crit Care. 2004. PMID: 15616383 Review.

2

Cardioprotection by volatile anesthetics.

Bienengraeber MW, Weihrauch D, Kersten JR, Pagel PS, Warltier DC. Bienengraeber MW, et al. Vascul Pharmacol. 2005 Apr-May;42(5-6):243-52. doi: 10.1016/j.vph.2005.02.005. Vascul Pharmacol. 2005. PMID: 15922257 Review.

3

Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.

Lee MC, Chen CH, Kuo MC, Kang PL, Lo A, Liu K. Lee MC, et al. Eur J Anaesthesiol. 2006 Oct;23(10):841-7. doi: 10.1017/S0265021506000354. Epub 2006 Mar 1. Eur J Anaesthesiol. 2006. PMID: 16507192 Clinical Trial.

4

Mechanisms of cardioprotection by isoflurane against I/R injury.

Lang XE, Wang X, Jin JH. Lang XE, et al. Front Biosci (Landmark Ed). 2013 Jan 1;18(1):387-93. doi: 10.2741/4109. Front Biosci (Landmark Ed). 2013. PMID: 23276931 Free article. Review.

5

Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applications.

Zaugg M, Lucchinetti E, Behmanesh S, Clanachan AS. Zaugg M, et al. Curr Pharm Des. 2014;20(36):5706-26. doi: 10.2174/1381612820666140204120829. Curr Pharm Des. 2014. PMID: 24502570 Review.

6

The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats.

Sato H, Bolli R, Rokosh GD, Bi Q, Dai S, Shirk G, Tang XL. Sato H, et al. Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2557-64. doi: 10.1152/ajpheart.00858.2007. Epub 2007 Aug 17. Am J Physiol Heart Circ Physiol. 2007. PMID: 17704286 Free PMC article.

7

Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection.

Wu L, Zhao H, Wang T, Pac-Soo C, Ma D. Wu L, et al. J Anesth. 2014 Oct;28(5):740-58. doi: 10.1007/s00540-014-1805-y. Epub 2014 Mar 9. J Anesth. 2014. PMID: 24610035 Review.

8

Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo.

Alcindor D, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Alcindor D, et al. Anesthesiology. 2004 Mar;100(3):547-54. doi: 10.1097/00000542-200403000-00013. Anesthesiology. 2004. PMID: 15108967 Free article.

9

Isoflurane-induced postconditioning via mitochondrial calcium-activated potassium channels.

Kinoshita M, Tsutsumi YM, Fukuta K, Kasai A, Tanaka K. Kinoshita M, et al. J Med Invest. 2016;63(1-2):80-4. doi: 10.2152/jmi.63.80. J Med Invest. 2016. PMID: 27040058 Free article.

10

Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model.

Karlsson LO, Zhou AX, Larsson E, Aström-Olsson K, Månsson C, Akyürek LM, Grip L. Karlsson LO, et al. J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):182-9. doi: 10.1177/1074248410362074. J Cardiovasc Pharmacol Ther. 2010. PMID: 20435992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results